California Equity Research Initiates Coverage of CardioDynamics Intl. With a Buy Rating
18 Décembre 2008 - 3:15PM
Marketwired
California Equity Research, LLC, a leading independent investment
research firm focused on California equities, is initiating
coverage of CardioDynamics International Corporation (NASDAQ: CDIC)
($0.60) with a Buy rating and price target of $3.50. The following
excerpts are from the CardioDynamics research report.
-- CardioDynamics shares are significantly undervalued trading at a TTM
revenue multiple of 0.17x.
-- CardioDynamics revenue is expected to grow at an 8% annual rate
through 2010 based on:
-- New initiatives and additions to sales and marketing
-- Next generation BioZ product to be released in late 2009
-- Growing traction in overseas markets particularly Eastern Europe
-- Important clinical studies due for release in 2010 on hypertension
and CHF
More information on the 21-page CardioDynamics research report
can be obtained by calling 866.928.2600 or by visiting online at
www.CalEquityResearch.com. Please refer to our website for a full
list of disclosures.
California Equity Research, LLC is an independent, research-only
investment firm that exclusively covers underfollowed opportunities
in California. Our research is produced by experienced analysts
that have one committed goal: providing timely, value-added
research ideas to our clients. For more information about
California Equity Research please visit us online at
www.CalEquityResearch.com or call 866.928.2600.
CONTACT: Bud Leedom Director of Research California Equity
Research, LLC 858.829.8688
Cardiodynamics International (MM) (NASDAQ:CDIC)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Cardiodynamics International (MM) (NASDAQ:CDIC)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about Cardiodynamics International (MM) (NASDAQ): 0 recent articles
Plus d'articles sur CardioDynamics International